PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Interest & Investment Income (2022 - 2026)

PepGen (PEPG) posted Interest & Investment Income of $1.2 million for Q1 2026, down 11.91% sequentially from $1.4 million in Q4 2025, and up 11.41% YoY from $1.1 million in Q1 2025.

Analysis

PepGen (PEPG) Interest & Investment Income (2022 - 2026) Analysis & Trends

PepGen has reported Interest & Investment Income for 5 years, with the latest figure at $1.2 million in Q1 2026.

  • Quarterly Interest & Investment Income rose 11.41% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (down 36.51% YoY) and the FY2025 annual result came in at $4.0 million, down 43.76% from the prior year.
  • Interest & Investment Income fell to $1.2 million in Q1 2026 per PEPG's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $2.1 million in Q2 2024 and troughed at $9000.0 in Q1 2022.
  • A 5-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 19811.11% in 2023, then slumped 65.28% in 2025.
  • Over 5 years, Interest & Investment Income stood at $1.6 million in 2022, then retreated by 15.4% to $1.3 million in 2023, then rose by 8.47% to $1.5 million in 2024, then retreated by 2.81% to $1.4 million in 2025, then decreased by 11.91% to $1.2 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $1.2 million, $1.4 million, and $634000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 PepGen 217.99 Mn 217.99 Mn - 1.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.09 Mn
Mar 31, 2026 1.25 Mn
Dec 31, 2025 1.42 Mn
Sep 30, 2025 634,000.00
Jun 30, 2025 842,000.00
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.46 Mn
Sep 30, 2024 1.83 Mn
Jun 30, 2024 2.12 Mn
Mar 31, 2024 1.74 Mn
Dec 31, 2023 1.35 Mn
Sep 30, 2023 1.58 Mn
Jun 30, 2023 1.68 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 943,000.00
Jun 30, 2022 250,000.00
Mar 31, 2022 9,000.00